A Randomized Clinical Trial of PF-05281104 Versus Herceptin® for Patients with HER2-Positive Breast Cancer (REFLECTIONS B327-04)

A Randomized, Double-Blind Pharmacokinetic Study Of PF-05280014 Plus Taxotere® And Carboplatin Versus
Herceptin® Plus Taxotere® And Carboplatin For The Neoadjuvant Treatment Of Patients With Operable HER2-Positive Breast Cancer

Category & Conditions:
Cancer
Medicine:
TRAZIMERA FOR INJECTION(TRASTUZUMAB-QYYP)
ClinicalTrials.gov Identifier (NCT):
Protocol ID:
B3271004
Open Plain Language Summary Result:Click here